Featured Research

from universities, journals, and other organizations

Study of bloodstream infections reveals inconsistent surveillance methods, reporting among hospitals

Date:
September 24, 2010
Source:
Elsevier
Summary:
A new study looking at how hospitals account for the number of pediatric patients who develop catheter-associated bloodstream infections (CA-BSIs) found substantial inconsistencies in the methods used to report the number of patients who develop these infections.

A new study looking at how hospitals account for the number of pediatric patients who develop catheter-associated bloodstream infections (CA-BSIs) found substantial inconsistencies in the methods used to report the number of patients who develop these infections.

The study, conducted by the National Association of Children's Hospitals and Related Institutions Pediatric Intensive Care Unit Focus Group, appears in the October issue of the American Journal of Infection Control, the official publication of the Association for Professionals in Infection Control and Epidemiology (APIC).

Bloodstream infections are the most common hospital-associated infection (HAI) in pediatric intensive care units (PICU) and a significant source of in-hospital deaths, increased length of stay and added medical costs. Both adult and pediatric patients who have catheters inserted into their blood vessels face increased risk of an infection developing along the invasive plastic devices which can become life-threatening as they spread into the bloodstream.

The study team, led by Matthew Niedner, MD, Assistant Professor of Pediatrics and Communicable Diseases, Mott Children's Hospital in Ann Arbor, Michigan, looked at surveillance practices at 10 PICUs.

"While 100% of surveyed infection control practitioners in the study indicated using the CDC's definition for CA-BSI, strictly speaking, none actually do," said Niedner, who authored the article. "This has significant implications in the era of mandatory public reporting, pay-for-performance and Medicare's 'never events.'" (The Centers for Medicare & Medicaid Services lists CA-BSIs as a "never event," and therefore no longer reimburses for such hospital-acquired infections.)

In addition to the analysis of the inconsistent surveillance methods, the study also showed that more aggressive surveillance efforts correlate with higher CA-BSI rates. In the words of the author, this suggests "that the harder one looks for CA-BSIs, the more likely they are to find them."

The author observes that the study's findings offer "a compelling opportunity" for hospitals to improve their CA-BSI surveillance as a means to promote valid comparison among institutions. The author points out that surveillance variability complicates comparison of CA-BSI rates between hospitals, which has implications for the public reporting of hospital infection rates. Current publicly reported data show that some hospitals report a four-fold difference in CA-BSI infection rates, according to the study. The author notes that effective quality improvement requires reliable measures of performance.

The author hopes this work spurs further research into improving hospital surveillance for CA-BSI. The author concludes: "Improved understanding of this variability and awareness of the potential consequences provides an opportunity and rationale to define CA-BSI surveillance best practices and work toward standardizing them across institutions."


Story Source:

The above story is based on materials provided by Elsevier. Note: Materials may be edited for content and length.


Journal Reference:

  1. Matthew F. Niedner. The harder you look, the more you find: Catheter-associated bloodstream infection surveillance variability. American Journal of Infection Control, 2010; 38 (8): 585 DOI: 10.1016/j.ajic.2010.04.211

Cite This Page:

Elsevier. "Study of bloodstream infections reveals inconsistent surveillance methods, reporting among hospitals." ScienceDaily. ScienceDaily, 24 September 2010. <www.sciencedaily.com/releases/2010/09/100924084604.htm>.
Elsevier. (2010, September 24). Study of bloodstream infections reveals inconsistent surveillance methods, reporting among hospitals. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2010/09/100924084604.htm
Elsevier. "Study of bloodstream infections reveals inconsistent surveillance methods, reporting among hospitals." ScienceDaily. www.sciencedaily.com/releases/2010/09/100924084604.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins